000850240 001__ 850240
000850240 005__ 20210129234534.0
000850240 0247_ $$2doi$$a10.1371/journal.pone.0199379
000850240 0247_ $$2Handle$$a2128/19388
000850240 0247_ $$2pmid$$apmid:29953478
000850240 0247_ $$2WOS$$aWOS:000436645400028
000850240 0247_ $$2altmetric$$aaltmetric:44258941
000850240 037__ $$aFZJ-2018-04295
000850240 082__ $$a500
000850240 1001_ $$0P:(DE-HGF)0$$aBlanc-Durand, Paul$$b0$$eCorresponding author
000850240 245__ $$aVoxel-based 18F-FET PET segmentation and automatic clustering of tumor voxels: A significant association with IDH1 mutation status and survival in patients with gliomas
000850240 260__ $$aLawrence, Kan.$$bPLoS$$c2018
000850240 3367_ $$2DRIVER$$aarticle
000850240 3367_ $$2DataCite$$aOutput Types/Journal article
000850240 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1531986532_29824
000850240 3367_ $$2BibTeX$$aARTICLE
000850240 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000850240 3367_ $$00$$2EndNote$$aJournal Article
000850240 520__ $$aIntroductionAim was to develop a full automatic clustering approach of the time-activity curves (TAC) from dynamic 18F-FET PET and evaluate its association with IDH1 mutation status and survival in patients with gliomas.MethodsThirty-seven patients (mean age: 45±13 y) with newly diagnosed gliomas and dynamic 18F-FET PET before any histopathologic investigation or treatment were retrospectively included. Each dynamic 18F-FET PET was realigned to the first image and spatially normalized in the Montreal Neurological Institute template. A tumor mask was semi-automatically generated from Z-score maps. Each brain tumor voxel was clustered in one of the 3 following centroids using dynamic time warping and k-means clustering (centroid #1: slowly increasing slope; centroid #2: rapidly increasing followed by slowly decreasing slope; and centroid #3: rapidly increasing followed by rapidly decreasing slope). The percentage of each dynamic 18F-FET TAC within tumors and other conventional 18F-FET PET parameters (maximum and mean tumor-to-brain ratios [TBRmax and TBRmean], time-to-peak [TTP] and slope) was compared between wild-type and IDH1 mutant tumors. Their prognostic value was assessed in terms of progression free-survival (PFS) and overall survival (OS) by Kaplan-Meier estimates.ResultsTwenty patients were IDH1 wild-type and 17 IDH1 mutant. Higher percentage of centroid #1 and centroid #3 within tumors were positively (P = 0.016) and negatively (P = 0.01) correlated with IDH1 mutated status. Also, TBRmax, TBRmean, TTP, and slope discriminated significantly between tumors with and without IDH1 mutation (P range 0.01 to 0.04). Progression occurred in 22 patients (59%) at a median of 13.1 months (7.6–37.6 months) and 13 patients (35%) died from tumor progression. Patients with a percentage of centroid #1 > 90% had a longer survival compared with those with a percentage of centroid #1 < 90% (P = 0.003 for PFS and P = 0.028 for OS). This remained significant after stratification on IDH1 mutation status (P = 0.029 for PFS and P = 0.034 for OS). Compared to other conventional 18F-FET PET parameters, TTP and slope were associated with PFS and OS (P range 0.009 to 0.04).ConclusionsBased on dynamic 18F-FET PET acquisition, we developed a full automatic clustering approach of TAC which appears to be a valuable noninvasive diagnostic and prognostic marker in patients with gliomas
000850240 536__ $$0G:(DE-HGF)POF3-573$$a573 - Neuroimaging (POF3-573)$$cPOF3-573$$fPOF III$$x0
000850240 588__ $$aDataset connected to CrossRef
000850240 7001_ $$00000-0001-8914-6927$$aVan Der Gucht, Axel$$b1
000850240 7001_ $$0P:(DE-Juel1)171957$$aVerger, Antoine$$b2
000850240 7001_ $$0P:(DE-Juel1)131777$$aLangen, Karl-Josef$$b3$$ufzj
000850240 7001_ $$0P:(DE-HGF)0$$aDunet, Vincent$$b4
000850240 7001_ $$0P:(DE-HGF)0$$aBloch, Jocelyne$$b5
000850240 7001_ $$0P:(DE-HGF)0$$aBrouland, Jean-Philippe$$b6
000850240 7001_ $$0P:(DE-HGF)0$$aNicod-Lalonde, Marie$$b7
000850240 7001_ $$0P:(DE-HGF)0$$aSchaefer, Niklaus$$b8
000850240 7001_ $$0P:(DE-HGF)0$$aPrior, John O.$$b9
000850240 773__ $$0PERI:(DE-600)2267670-3$$a10.1371/journal.pone.0199379$$gVol. 13, no. 6, p. e0199379 -$$n6$$pe0199379 -$$tPLoS one$$v13$$x1932-6203$$y2018
000850240 8564_ $$uhttps://juser.fz-juelich.de/record/850240/files/journal.pone.0199379.pdf$$yOpenAccess
000850240 8564_ $$uhttps://juser.fz-juelich.de/record/850240/files/journal.pone.0199379.gif?subformat=icon$$xicon$$yOpenAccess
000850240 8564_ $$uhttps://juser.fz-juelich.de/record/850240/files/journal.pone.0199379.jpg?subformat=icon-1440$$xicon-1440$$yOpenAccess
000850240 8564_ $$uhttps://juser.fz-juelich.de/record/850240/files/journal.pone.0199379.jpg?subformat=icon-180$$xicon-180$$yOpenAccess
000850240 8564_ $$uhttps://juser.fz-juelich.de/record/850240/files/journal.pone.0199379.jpg?subformat=icon-640$$xicon-640$$yOpenAccess
000850240 909CO $$ooai:juser.fz-juelich.de:850240$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000850240 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131777$$aForschungszentrum Jülich$$b3$$kFZJ
000850240 9131_ $$0G:(DE-HGF)POF3-573$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$vNeuroimaging$$x0
000850240 9141_ $$y2018
000850240 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000850240 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000850240 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000850240 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000850240 915__ $$0StatID:(DE-HGF)1040$$2StatID$$aDBCoverage$$bZoological Record
000850240 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bPLOS ONE : 2015
000850240 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000850240 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000850240 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000850240 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000850240 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000850240 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000850240 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000850240 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000850240 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000850240 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000850240 9201_ $$0I:(DE-Juel1)INM-4-20090406$$kINM-4$$lPhysik der Medizinischen Bildgebung$$x0
000850240 980__ $$ajournal
000850240 980__ $$aVDB
000850240 980__ $$aUNRESTRICTED
000850240 980__ $$aI:(DE-Juel1)INM-4-20090406
000850240 9801_ $$aFullTexts